HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic s
- This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
https://www.ncbi.nlm.nih.gov/pubmed/30885276
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.